Skip to main content
. 2022 Jan 31;18(9):2216–2228. doi: 10.1080/15548627.2022.2025571

Figure 7.

Figure 7.

HDM-challenged atg5−/− obese mice develop TSLP-dependent and IL33-dependent asthma. (A) Experimental timeline. atg5−/− obese mice and WT obese mice were immunized as described in Figure 1A. Anti-thymic stromal lymphoprotein (TSLP) antibody (20 μg), anti-IL33 antibody (6 μg), or isotype controls were intranasally administered before HDM challenges. (A and D) Lung resistance (RL), (B and E) Differential cell counts in BALF. TCC, total cell count; MAC, macrophages; Ly, lymphocytes; Eo, eosinophils; Neut, neutrophils. (C and F) Hematoxylin and eosin-staining. Original magnification: 100 × . (E) PAS staining. Data are representative of two independent experiments (n = 5–7/group). Data are expressed as the mean ± SEM. P-values were calculated using two-way ANOVA test post hoc test with the Tukey’s multiple comparison test. *, P < 0.05, **, P < 0.01, ***, P < 0.001.